Pharma: The dubious billion-dollar business with menopausal women
Quick Look
- Investors and pharmaceutical companies are discovering the potential of menopause products.
- By removing the taboo on the topic on social media and through prominent support, billions are flowing into telemedicine and special employee benefits.
AI-generated summary
Why It Matters
The issue of menopause has long been ignored by society and neglected by investors.
Munich. For decades, investors and pharmaceutical companies have paid little attention to the symptoms women experience during menopause - even though this affects more than half of the world's population over the course of their lives. But now hot flashes are suddenly becoming hot business.
Financial investors and private donors are pumping billions into selling products for women during menopause. Telemedicine providers promote hormone therapies. Programs for menopausal women are becoming the latest “employee benefit” in companies.
Gone are the days when women endured the symptoms in silence and the topic of menopause was ignored in public. Influencers and celebrities like Oprah Winfrey and Serena Williams promote menopause products, and the hashtag #menopause has billions of views on Tiktok.
Open Questions
- How sustainable is growth in this niche market?
